Similarities vs. key discrepancy between tuberculosis and cancer
Peter Richmond, Bertrand M. Roehner

TL;DR
This paper compares tuberculosis and cancer, revealing similarities in organ response patterns and suggesting shared vulnerabilities in immune protection, which could inform future research and treatment strategies.
Contribution
It introduces a comparative analysis of TB and cancer responses across organs using spectrometric data, highlighting parallel development patterns and immune system vulnerabilities.
Findings
Organ response patterns to TB and cancer are similar across multiple organs.
Both diseases show peak mortality at similar ages, e.g., brain tumors around age 10.
Shared immune vulnerabilities may exist across different diseases and organs.
Abstract
In 2015 in the United States 612,000 persons died from cancer whereas only 470 died from tuberculosis (TB), a disease which was the main cause of death around 1900. How can one explain such a key discrepancy in treatment progress? A statistical comparison between TB and cancer will give some clues. However, TB and cancer also share several important features. Both TB and cancer can affect several organs, e.g. lungs, brain, bones, intestines, skin. What in cancer is called malignant neoplasm (tumor) is called granuloma in TB. By isolating malignant cells (versus bacteria) from the rest of the body, such clusters protect the host's organism but at the same time they are "secure beachheads" from where malignant cells (versus infected macrophages) can wander off to new locations. Thus, metastatic tumors have a TB parallel in the form of secondary granulomas. In order to investigate more…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTuberculosis Research and Epidemiology · Computational Drug Discovery Methods · Biosimilars and Bioanalytical Methods
